# BEND5

## Overview
BEND5 is a gene that encodes the protein BEN domain containing 5, which is characterized by the presence of a BEN domain, a motif involved in chromatin organization and transcriptional regulation. The BEND5 protein plays a significant role in cellular processes by interacting with key signaling pathways, such as the Notch and PPAR pathways, and is implicated in the regulation of cell proliferation and migration. It functions as a tumor suppressor in various cancers, including lung adenocarcinoma and breast cancer, by modulating these pathways and influencing cancer cell behavior (Ma2023Investigation; Shi2022Interaction). BEND5's involvement in chromatin structure maintenance and its potential interactions with other proteins suggest a broader role in cellular homeostasis and gene expression regulation (Ma2023Investigation).

## Clinical Significance
BEND5 has been implicated in various cancers, primarily due to its altered expression levels. In lung adenocarcinoma (LUAD), BEND5 expression is significantly decreased, suggesting its role as a potential tumor suppressor. Low BEND5 expression in LUAD is associated with poor prognosis and increased tumor progression. Overexpression of BEND5 in LUAD cells has been shown to inhibit cell proliferation by activating the peroxisome proliferator-activated receptor (PPAR) signaling pathway, indicating its potential as a therapeutic target (Ma2023Investigation).

In breast cancer, BEND5 acts as a tumor suppressor by inhibiting Notch signaling, a pathway crucial for cancer cell proliferation and metastasis. BEND5 achieves this by binding to RBPJ, a transcriptional activator in the Notch pathway, thereby disrupting the formation of a transcription activation complex. This interaction results in reduced breast cancer cell proliferation, migration, and invasion, highlighting BEND5's potential as a therapeutic target in breast cancer (Shi2022Interaction).

BEND5 expression is also linked to drug sensitivity in various cancers, suggesting its role in influencing treatment responses. Its expression levels correlate with sensitivity to drugs like Nelarabine and Chelerythrine, indicating potential implications for personalized cancer therapy (Fan2022The).

## Interactions
BEND5, a protein encoded by the BEND5 gene, is known to interact with RBPJ, a key component of the Notch signaling pathway. This interaction is mediated through the BEN domain of BEND5 and the N-terminal domain (NTD) of RBPJ. BEND5 binds to RBPJ but does not interact with other Notch pathway components such as NICD or MAML. The binding of BEND5 to RBPJ disrupts the interaction between RBPJ and MAML, inhibiting the formation of a transcription activation complex and thereby suppressing Notch signaling. This mechanism is crucial for BEND5's role in inhibiting breast cancer cell proliferation, migration, and invasion (Shi2022Interaction).

In lung adenocarcinoma (LUAD), BEND5 is involved in the PPAR signaling pathway, where its overexpression inhibits cell proliferation. Although specific protein interactions in LUAD are not detailed, BEND5's role in chromatin structure maintenance and its involvement in signaling pathways suggest it may participate in complex protein interactions (Ma2023Investigation). The protein-protein interaction network analysis identifies potential interactions of BEND5 with proteins such as KCNH4, PRSS12, and COL24A1, indicating its involvement in broader cellular processes (Ma2023Investigation).


## References


1. (Fan2022The) The Diagnostic and Prognostic Value of BEN-Domain (BEND) Family Genes in Gastric Cancer. This article has 1 citations.

[2. (Ma2023Investigation) Yuting Ma and Liyang Wu. Investigation of the function of the novel tumor marker bend5 in lung adenocarcinoma based on data mining and in vitro analysis. Journal of Thoracic Disease, 15(4):1749–1769, April 2023. URL: http://dx.doi.org/10.21037/jtd-23-314, doi:10.21037/jtd-23-314. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/jtd-23-314)

[3. (Shi2022Interaction) Yanzhu Shi, Deyu Zhang, Jingyi Chen, Qiwei Jiang, Songze Song, Yue Mi, Tao Wang, and Qinong Ye. Interaction between bend5 and rbpj suppresses breast cancer growth and metastasis via inhibiting notch signaling. International Journal of Biological Sciences, 18(10):4233–4244, 2022. URL: http://dx.doi.org/10.7150/ijbs.70866, doi:10.7150/ijbs.70866. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.70866)